According to the Zhitong Finance App, First Pharmaceutical (600833.SH) disclosed its report for the first quarter of 2023. During the reporting period, the company achieved revenue of 459 million yuan, an increase of 17.29% over the previous year; Guimu's net profit of 29.61 million yuan, an increase of 373.18% over the previous year; after deducting non-net profit of 7.88 million yuan, an increase of 28.8% over the previous year; and basic earnings per share of 0.1327 yuan.
第一医药(600833.SH)发布一季度业绩，净利润2961万元，同比增长373.18%
First Pharmaceutical (600833.SH) released first-quarter results, with net profit of 29.61 million yuan, an increase of 373.18% over the previous year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.